KAT8
KAT8 Regulatory NSL Complex Subunit 1 (KAT8), also known as MYST Histone Acetyltransferase 1 (MYST1) or MOZ, YBF2/SAS3, SAS2, and TIP60 protein 1, is a protein that in humans is encoded by the KAT8 gene. KAT8 is a member of the MYST family of histone acetyltransferases (HATs), which play a crucial role in the regulation of gene expression through modification of chromatin structure. This protein is involved in the acetylation of histone H4, a process essential for chromatin remodeling and transcriptional activation.
Function
KAT8 is a core component of the non-specific lethal (NSL) complex, which is known to acetylate the lysine 16 on histone H4 (H4K16ac), a key epigenetic marker associated with DNA repair, replication, and transcriptional activation. The acetylation of H4K16 plays a significant role in the decondensation of chromatin structure, facilitating access for transcription factors and other regulatory proteins. KAT8 also targets other non-histone proteins for acetylation, indicating its diverse roles in cellular processes beyond transcriptional regulation.
Clinical Significance
Mutations and dysregulation of KAT8 have been implicated in various human diseases, including cancer. The alteration in histone acetylation patterns due to aberrant KAT8 activity can lead to changes in gene expression profiles, contributing to tumorigenesis and progression. Furthermore, KAT8 is involved in DNA damage response and repair mechanisms, making it a potential target for cancer therapy. Research is ongoing to explore the therapeutic implications of modulating KAT8 activity in cancer and other diseases.
Interactions
KAT8 interacts with several proteins within the NSL complex, including KANSL1, KANSL2, and KANSL3, which are essential for its HAT activity and proper localization to target genes. It also interacts with other histone modifiers and transcription factors, highlighting its integration into a complex network of regulatory pathways that govern gene expression and cellular function.
See Also
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD